Virtual reality for pain management
How VR retrains the brain's body map, and what the research shows.
A person can finish a pain program walking further, sleeping through the night, and back at work, while still rating their pain a 5. If the only number anyone recorded was the 5, the program looks like it failed. It did not. The measurement did.
How is progress measured in chronic pain rehabilitation?
Progress in chronic pain rehabilitation is measured across several domains, not pain intensity alone. Standard practice tracks pain, physical function, fear of movement, mood, sleep, and the patient's own rating of change, using validated questionnaires repeated at intervals. A meaningful result is a change large enough for the patient to notice and value, and function often improves before pain does.
The field settled this question in 2005, when an international consensus group recommended that every chronic pain trial report at least six outcome domains, with pain intensity being only one of them.
Because it answers a narrow question, how much does it hurt right now, and chronic pain rehabilitation is trying to change something wider. The 0–10 numeric rating scale was built for acute pain, where intensity is the whole clinical picture. In pain that has lasted months or years, intensity is one piece of a picture that also includes sleep, mood, work, movement, and the beliefs that govern all of them.
Three problems show up when a program relies on the pain score alone.
None of this means the pain score should be dropped. It is quick, validated, and patients care about it. It means the score should sit in a row with other measures rather than standing alone. The wider family of pain scales is covered in chronic pain scales.
The clearest answer comes from the IMMPACT consensus, a group of pain researchers, regulators, and patient representatives who agreed in 2005 on what every chronic pain trial should report. Their six core domains are pain, physical functioning, emotional functioning, the patient's global rating of improvement and satisfaction, symptoms and adverse events, and participant disposition, meaning who stayed in treatment and who dropped out. A clinical program is not a trial, but the same domains are a reasonable yardstick for what a good one should be tracking.
| Domain | Example measure | What it tells you |
|---|---|---|
| Pain intensity | Numeric Rating Scale (NRS, 0–10) | How much it hurts, averaged over a recall period such as the past week |
| Physical function | Oswestry Disability Index (back pain); PROMIS Physical Function | What the person can do: lifting, walking, sitting, self-care, stairs |
| Fear of movement | Fear-Avoidance Beliefs Questionnaire (FABQ); Tampa Scale for Kinesiophobia (TSK) | Whether the belief that movement is dangerous is limiting activity (more) |
| Catastrophizing | Pain Catastrophizing Scale (PCS) | Rumination, magnification, and helplessness, which predict disability and treatment response |
| Sleep | Sleep quality or interference item, or a validated sleep questionnaire | Whether pain is still breaking up the night, a strong driver of next-day pain and mood |
| Global impression of change | Patient Global Impression of Change (PGIC) | The patient's own 7-point verdict, from 'very much worse' to 'very much improved' |
| Patient-specific goals | Patient-Specific Functional Scale (PSFS) | Progress on the three to five activities the patient named as mattering most to them |
| Work status | Hours worked, duties, restrictions, return-to-work date | The outcome employers, insurers, and many patients care about most |
| Program engagement | Sessions completed, coaching attendance, dropout | Whether the dose was delivered; results from people who stopped early mean something different |
No program measures everything on this list, and a questionnaire burden that drives people away is its own harm. A sensible minimum is pain intensity, one function measure, one belief measure, and the patient's global rating, taken at baseline and again at fixed points. For how to ask a remote program what it tracks, see how to evaluate a remote pain rehabilitation program.
Of all the rows above, the belief measures are the ones most often skipped and most often decisive. Fear-avoidance beliefs about work predicted work loss more strongly than pain severity in the original FABQ study. A program that does not measure fear cannot tell you whether it has treated it.
A change big enough for the patient to notice and value. Researchers call this the minimal clinically important difference (MCID), and it is a different thing from statistical significance. A large study can find a statistically significant change too small for any individual to feel. The MCID asks the opposite question: how much does a score need to move before the person behind it says 'yes, that helped'?
The ODI scores back-related disability from 0% to 100%. Suppose someone starts a program at 46%, which sits in the 'severe' band, and finishes at 34%, which is 'moderate'. Is a 12-point drop real progress or noise? The ODI literature puts the smallest change patients consider worthwhile at around 10 points on the 0–100 scale, so a 12-point improvement clears that bar. A drop from 46% to 42% would not, and should be reported as 'no meaningful change yet' rather than dressed up as progress. The scoring bands and the MCID discussion are on the Oswestry Disability Index page.
For the 0–10 scale, the best-known anchor comes from a study that compared changes in pain score against what patients said on a global impression question. A reduction of roughly 2 points, or about 30%, corresponded to patients describing themselves as 'much improved'. A 6 becoming a 4 is a meaningful result by that standard, even though it is not a zero.
Two cautions. Thresholds depend on the starting point: a 10-point ODI drop means something different at 70% than at 22%, which is why some researchers prefer a relative change, such as 30% from the person's own baseline. And thresholds describe what one person would notice in their own score over time. They do not license comparing one patient's 34% against another's.
Yes, and in chronic pain it is the usual order of events rather than the exception. The sequence is predictable once you look at what rehabilitation actually changes first.
Consider a delivery driver two years after a back injury. She rates her pain a 6. She has stopped lifting her daughter, sits only on hard chairs, and sleeps about four hours. Over twelve weeks of graded exposure she starts lifting her again, sits through a film, and sleeps six hours. Her pain is still a 6. On the pain score nothing has happened. On the Oswestry she has moved two bands, her FABQ has fallen, and her PGIC says 'much improved'.
This happens because much of chronic pain disability is driven by avoidance rather than by the sensation itself. When fear drops, activity expands, and the activity expands before the nervous system has finished turning the alarm down. The fear-avoidance model describes this loop in detail, and the mechanism behind the slow pain change is covered in central sensitization.
If the only number on the chart is pain, the first three months of most recoveries are invisible.
There is a practical consequence. A patient who is told 'your pain score hasn't changed, so this isn't working' at week six may abandon a program that is working. The function and belief measures exist to make that early change visible, to the patient as much as to the clinician.
Karuna Virtual Embodiment Training (KVET)™ is a 12-week program done at home, with short daily VR sessions on a provided headset, a weekly one-on-one session with a dedicated pain coach, and a clinician who reviews the case before the start and oversees it throughout. Measures are taken before and after the program, and the coach reviews progress with the patient each week and adjusts the plan. The measures Karuna reports are chosen to match the domains above: pain, activity, fear-avoidance, confidence, and sleep, with the FABQ as the fear instrument. Karuna has also used the Oswestry and the Pain Catastrophizing Scale as outcome measures in an institutional review board–approved feasibility study of the technology.
The table below is Karuna's published outcome data, from a real-world evidence analysis of 50 patients. All of them were injured at work, covered under workers' compensation, and in pain for longer than six months. The caveats underneath are part of the result, not a footnote to it.
| Measure | Patients who improved | Median improvement |
|---|---|---|
| Fear-avoidance, physical activity (FABQ-PA) | 76% | 25% |
| Average pain | 71% | 28% |
| Average activity level | 74% | 49% |
| Confidence | 79% | 71% |
| Sleep quality | 67% | 33% |
The pattern is the point of this page. Activity and confidence moved further than pain did: a median of 49% and 71% among those who improved, against 28% for pain. That is the shape you would expect if fear and avoidance, rather than pain intensity, were the main limit on what these patients could do, and it is the shape a pain-only dashboard would have missed entirely.
How to read this table: it is uncontrolled real-world evidence, not a clinical trial. There was no control group, so it cannot show that the program caused the change; people change over time for many reasons. The sample is small and specific, 50 workers' compensation patients, and may not generalize. All measures are self-reported. Between 21% and 33% of patients did not improve on any given measure. Median improvement is reported among those who improved, so it does not describe the average patient. None of these figures is a success rate. The full discussion is on how Karuna works.
Start with the baseline and the instrument, not with the headline number. A report that cannot answer 'compared with what, measured how' has not reported anything yet.
A clean report is often less dramatic than a misleading one. 'Oswestry 46% to 34%, FABQ-PA down, PGIC much improved, 31 of 36 sessions completed, pain NRS 6 to 5' is an honest account of a good outcome. It will not fit on a billboard, and that is a point in its favor.
Ask any program you are considering what it measures, when, and whether you will see your own scores. Then ask for them. Writing down an Oswestry or FABQ score at the start and again at twelve weeks is often the clearest evidence a person has that something is changing, especially during the stretch when pain intensity has not moved yet. Track function weekly rather than pain hourly; close monitoring of pain tends to raise it.
Measurement is for pain that has already been medically evaluated. New weakness or numbness, loss of bowel or bladder control, unexplained weight loss, fever, pain after a major fall or accident, chest pain, or thoughts of harming yourself need prompt medical attention, not a questionnaire.
Pair the NRS with one function measure matched to the region (the ODI for low back, a PROMIS short form where no regional tool fits) and one belief measure, and repeat them on a schedule rather than when a patient seems better. Report change against published thresholds and against the patient's own baseline. When a remote program sends you outcomes, apply the checklist above before accepting the summary. A remote or at-home program that cannot show its instruments is asking you to take its word for it.
Work status is the outcome you are accountable for, and the FABQ work subscale is one of the better predictors of it. Ask for it at intake and at discharge. Treat a report with baseline, named instruments, engagement data, and an honest non-responder count as the standard, and treat a single headline percentage as a request for more information. Karuna takes workers' compensation referrals, and the care team confirms coverage case by case.
A single question that asks the patient to rate their overall change since starting treatment on a 7-point scale, from 'very much worse' through 'no change' to 'very much improved'. It is short enough to repeat often and it captures the patient's own verdict, which is why outcome researchers use it as the anchor for deciding what size of score change counts as meaningful.
On its own it is coarse. Alongside pain, function, and belief measures it answers the question the other scores cannot: does the patient think this was worth it?
At baseline, at least once mid-course, and at the end, with the same instruments each time. Many programs add a follow-up some months after discharge, since what matters in chronic pain is whether gains hold.
More often than that is not necessarily better. Frequent pain ratings increase attention on pain, and attention on pain tends to increase it. Weekly function or activity measures are a reasonable middle ground.
PROMIS is a set of patient-reported outcome measures developed with US federal funding to work across conditions. The Physical Function scale asks about everyday activities such as climbing stairs, carrying groceries, and getting out of a chair, and it is not tied to one body region.
The Oswestry was built and validated for low back pain and should be used there. PROMIS Physical Function is the better choice when pain is widespread, affects several regions, or sits somewhere no regional questionnaire covers.
Because they move with pain in both directions. Poor sleep lowers the pain threshold the next day, low mood raises catastrophizing, and both reduce the activity that recovery depends on. Emotional functioning is one of the six core outcome domains for exactly this reason.
Asking about mood is not a suggestion that the pain is psychological. The pain is real. Mood and sleep are part of the system that produces it, and they are often the parts that respond first.
Validated instruments such as the Oswestry and the FABQ are widely used in occupational and insurance settings as a standardized record of functional limitation and of change over time. They are self-report measures, so they document what the person reports rather than proving it, and they sit alongside clinical findings rather than replacing them.
If you are completing questionnaires for a claim, ask for copies of your scores and the dates. A consistent series is far more persuasive than a single reading.
Talk with our care team about your pain, your history, and whether KVET™ is right for you. Free, and from the comfort of home.